Cancer Family

Hematopoietic and Lymphatic System Neoplasm

Non-malignant4,305 active trials98 approved drugs1,010 evidence items

NCIt: C35813

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (684)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 684 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The Childhood Cancer and Leukemia International Consortium (CLIC): Expanding global collaboration in pediatric cancer etiology research.
Ana M Mora, Juan Manuel Mejía-Arangure, John D Dockerty et al. · Cancer Epidemiol · Oct 1, 2026 · PMID 42628293 · candidate dictionary pubmed
TIGIT-associated immune cell exhaustion in pediatric B-cell acute lymphoblastic leukemia: An integrated clinical and transcriptomic analysis.
Fatemah S Basingab · Clin Immunol · Oct 1, 2026 · PMID 42617963 · candidate dictionary pubmed
Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes.
Ke Wang, Fei Wang, Ye Jin et al. · Transpl Immunol · Oct 1, 2026 · PMID 42617955 · candidate dictionary pubmed
Reply to: Comment on: Evaluation of the Utility of Baseline Echocardiogram in Patients With Standard Risk Precursor B-Lymphoblastic Leukemia.
Ziyad Alrajhi, Alice Pozza, Luc Mertens et al. · Pediatr Blood Cancer · Oct 1, 2026 · PMID 42605746 · candidate dictionary pubmed
Alkyl-chain-length-associated responses of K562 leukemia cells to methyl-, ethyl-, and butylparaben with a focus on PPARγ and WNT/β-catenin signaling.
Konrad A Szychowski, Bartosz Skóra · Toxicol Appl Pharmacol · Oct 1, 2026 · PMID 42586446 · candidate dictionary pubmed
Pegaspargase Rechallenge Following Grade 2 Hypersensitivity Reaction in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 16-001.
Melissa A Burns, Yael Flamand, Julia Keating et al. · Pediatr Blood Cancer · Oct 1, 2026 · PMID 42578524 · candidate dictionary

pubmed

Low Dasatinib Penetration of the Blood-Brain Barrier in Children With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Evidence From LC-MS/MS Analysis.

Fangyuan Zheng, Mingming Ding, Aidong Lu et al. · Pediatr Blood Cancer · Oct 1, 2026 · PMID 42578491 · candidate dictionary pubmed

CD200 is a potent new growth factor in Multiple Myeloma dependent on IGF1 receptor signaling.

Angélique Bruyer, Nicolas Robert, Jules Varbedian et al. · Transl Oncol · Oct 1, 2026 · PMID 42664786 · candidate dictionary pubmed

Single-cell and bulk transcriptomic profiling of M2-like tumor-associated macrophages reveals a prognostic signature and an inflammation-metabolism crosstalk program in multiple myeloma.

Hui Zhao, Jing Kang, Huiling Ouyang et al. · Transl Oncol · Oct 1, 2026 · PMID 42636658 · candidate dictionary pubmed

Revision and complication rates after total joint arthroplasty in patients with monoclonal gammopathy of undetermined significance and multiple myeloma.

Jacob D Kodra, Austen Schweinert, Abdullah A Memon et al. · Int Orthop · Oct 1, 2026 · PMID 42706455 · candidate dictionary pubmed

Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial.

Martin F Kaiser, Rachel H Phillip, Sarah R Brown et al. · Lancet Oncol · Oct 1, 2026 · PMID 42705255 · candidate dictionary pubmed

Economic advantage of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: A cost-per-responder evaluation.

Santosh Gautam, Laura Morrison, Philippe Thompson-Leduc et al. · J Manag Care Spec Pharm · Oct 1, 2026 · PMID 42726291 · candidate dictionary pubmed

Targeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions.

Devangi Ghosh, Mohd Ayoub, Surajit Karmakar et al. · Curr Oncol Rep · Sep 29, 2026 · PMID 42809184 · candidate dictionary pubmed

Repurposing the Neurokinin-1 receptor antagonist Aprepitant to eradicate relapsed/refractory acute lymphoblastic leukemia via mitochondria-driven necroptosis.

Gang Shao, Hanling Pan, Jiayi Zhu et al. · Cancer Lett · Sep 28, 2026 · PMID 42184918 · candidate dictionary pubmed

Renal risk differences between diffuse large B-cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: implications for supportive oncology care.

Syed E Pasha, Sumon Khalique, Rakahn Haddadin et al. · Support Care Cancer · Sep 28, 2026 · PMID 42806171 · candidate dictionary pubmed

Diagnostic yield of cancer predisposition in a nationwide prospective childhood acute leukemia cohort.

Fulya Taylan, Anna Staffas, Sara Sjögren et al. · Nat Commun · Sep 28, 2026 · PMID 42806009 · candidate dictionary pubmed

Abemaciclib and lenalidomide presenting with central retinal artery occlusion in a patient with breast cancer and multiple myeloma: a possible treatment-related association.

Manas Pustake, Stevenson Ongsyping, Jesus Gomez et al. · BMJ Case Rep · Sep 28, 2026 · PMID 42805625 · candidate dictionary pubmed

Machine learning-driven M2 macrophage signature for precision prediction of survival and therapy response in acute myeloid leukemia.

Fangmin Zhong, Jing Liu, Jingze Yue et al. · Inflamm Res · Sep 27, 2026 · PMID 42802232 · candidate dictionary pubmed

ATM mutations in myelodysplastic neoplasms, acute myeloid leukemia, and myeloproliferative neoplasms: a systematic review.

Lucas Oliveira Laurindo, Marjori Lima Boblitz Parente, Greyce Luri Sasahara et al. · Med Oncol · Sep 25, 2026 · PMID 42789026 · candidate dictionary pubmed

MLN4924 promotes the transcriptional activation of BTG2 via the ROS/EGR1-mediated signaling axis to suppress acute myeloid leukemia progression.

Xiao Tang, Jinli Jian, Yuancheng Guo et al. · Acta Biochim Biophys Sin (Shanghai) · Sep 25, 2026 · PMID 41496600 · candidate dictionary pubmed

Venetoclax plus pediatric regimen in adolescents and adults with Ph-negative acute lymphoblastic leukemia.

Xiaoyuan Gong, Yuntao Liu, Qiuyun Fang et al. · Blood · Sep 24, 2026 · PMID 42166560 · candidate dictionary pubmed

NSD2 degradation remediates the oncogenic cistrome in t(4;14) multiple myeloma.

Bo Hu, Jacob T Edwards, Hardik Modi et al. · Blood · Sep 24, 2026 · PMID 42371798 · candidate dictionary pubmed

Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia.

Xiancheng Wu, Mazyar Shadman, Jenna Voutsinas et al. · Blood Adv · Sep 22, 2026 · PMID 42466974 · candidate dictionary pubmed

Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma.

Simon Leiders, Dominic Ufton, Helen Kaul et al. · Blood Adv · Sep 22, 2026 · PMID 42379221 · candidate dictionary pubmed

Evolution of real-world frontline treatment patterns in multiple myeloma.

Alexander Lazzaro, Kaelyn Nannini, Cenk Yildirim et al. · Blood Adv · Sep 22, 2026 · PMID 42480210 · candidate dictionary pubmed